FI875503A - 2,3-disubstituerade isoxazolidiner, foerfarande foer deras framstaellning, dessa innehaollande aemnen och deras anvaendning. - Google Patents

2,3-disubstituerade isoxazolidiner, foerfarande foer deras framstaellning, dessa innehaollande aemnen och deras anvaendning. Download PDF

Info

Publication number
FI875503A
FI875503A FI875503A FI875503A FI875503A FI 875503 A FI875503 A FI 875503A FI 875503 A FI875503 A FI 875503A FI 875503 A FI875503 A FI 875503A FI 875503 A FI875503 A FI 875503A
Authority
FI
Finland
Prior art keywords
deras
isoxazolidiner
disubstituerade
foerfarande foer
anvaendning
Prior art date
Application number
FI875503A
Other languages
English (en)
Other versions
FI875503A0 (fi
FI88303B (fi
FI88303C (fi
Inventor
Stephan Henke
Dietrich Brocks
Volkmar Guenzler
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI875503A0 publication Critical patent/FI875503A0/fi
Publication of FI875503A publication Critical patent/FI875503A/fi
Publication of FI88303B publication Critical patent/FI88303B/fi
Application granted granted Critical
Publication of FI88303C publication Critical patent/FI88303C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI875503A 1986-12-17 1987-12-15 Foerfarande foer framstaellning av terapeutiskt anvaendbara 2,3-disubstituerade isoxazolidiner FI88303C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3643012 1986-12-17
DE19863643012 DE3643012A1 (de) 1986-12-17 1986-12-17 2,3-disubstituierte isoxazolidine, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung

Publications (4)

Publication Number Publication Date
FI875503A0 FI875503A0 (fi) 1987-12-15
FI875503A true FI875503A (fi) 1988-06-18
FI88303B FI88303B (fi) 1993-01-15
FI88303C FI88303C (fi) 1993-04-26

Family

ID=6316346

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875503A FI88303C (fi) 1986-12-17 1987-12-15 Foerfarande foer framstaellning av terapeutiskt anvaendbara 2,3-disubstituerade isoxazolidiner

Country Status (21)

Country Link
US (2) US5422342A (fi)
EP (1) EP0271865B1 (fi)
JP (1) JP2703912B2 (fi)
KR (1) KR960010349B1 (fi)
AR (1) AR246528A1 (fi)
AT (1) ATE81344T1 (fi)
AU (1) AU599177B2 (fi)
CA (1) CA1338484C (fi)
DE (2) DE3643012A1 (fi)
DK (1) DK171894B1 (fi)
ES (1) ES2052539T3 (fi)
FI (1) FI88303C (fi)
GR (1) GR3006699T3 (fi)
HU (1) HU201961B (fi)
IE (1) IE61034B1 (fi)
IL (1) IL84841A (fi)
NO (1) NO175058B (fi)
NZ (1) NZ222921A (fi)
PH (1) PH24746A (fi)
PT (1) PT86380B (fi)
ZA (1) ZA879400B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818850A1 (de) * 1988-06-03 1989-12-07 Hoechst Ag Oligopeptide mit zyklischen prolin-analogen aminosaeuren
DD284030A5 (de) 1988-11-24 1990-10-31 Hoechst Ag,De Verfahren zur herstellung von peptiden mit bradykinin-antagonistischer wirkung
DE3842197A1 (de) * 1988-12-15 1990-06-21 Hoechst Ag Rasch spaltbares substrat fuer die hiv-protease
DE4016596A1 (de) * 1990-05-23 1991-11-28 Hoechst Ag Ein neues kupplungsreagenz fuer die peptidsynthese
LT3872B (en) 1993-12-06 1996-04-25 Hoechst Ag Novel peptides and pharmaceutical compositions containing them
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
PT796855E (pt) 1996-03-20 2002-07-31 Hoechst Ag Inibicao da reabsorcao nos ossos e antagonistas de vitronectina
FR2746394B1 (fr) 1996-03-20 1998-05-29 Roussel Uclaf Nouveaux composes tricycliques, leur procede de preparation, et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
US5801187A (en) * 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
DE19653647A1 (de) 1996-12-20 1998-06-25 Hoechst Ag Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
DE19741235A1 (de) 1997-09-18 1999-03-25 Hoechst Marion Roussel De Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19741873A1 (de) * 1997-09-23 1999-03-25 Hoechst Marion Roussel De Gmbh Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19751251A1 (de) 1997-11-19 1999-05-20 Hoechst Marion Roussel De Gmbh Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
DE19821483A1 (de) 1998-05-14 1999-11-18 Hoechst Marion Roussel De Gmbh Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
US7141589B2 (en) * 2001-08-23 2006-11-28 The United States Of America As Represented By The Department Of Health And Human Services Methods of inhibiting formation of vascular channels and methods of inhibiting proliferation
RU2416606C2 (ru) * 2004-06-17 2011-04-20 Инфинити Дискавери, Инк. Соединения и способы для ингибирования взаимодействия bcl белков с компонентами по связыванию
US7842815B2 (en) 2004-06-17 2010-11-30 Infinity Pharmaceuticals, Inc. Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
TWI389895B (zh) 2006-08-21 2013-03-21 Infinity Discovery Inc 抑制ｂｃｌ蛋白質與結合夥伴間之交互作用的化合物及方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3944562A (en) * 1974-04-17 1976-03-16 The Upjohn Company αS, 4S, 5R α-Amino-3-chloro-4-hydroxy-2-isoxazoline-5-acetic acid
US4269772A (en) * 1980-01-14 1981-05-26 Merck & Co., Inc. Synthesis of thienamycin via trans-3-carboxymethylene-4-carboxy-5-methyl-Δ2 -isoxazoline
DE3002989A1 (de) * 1980-01-29 1981-07-30 Hoechst Ag, 6000 Frankfurt Hydroxyphenyl-thiazol, -thiazolin und -thiazolidin-carbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung zur beeinflussung des kollagenstoffwechsels
US4562187A (en) * 1985-01-22 1985-12-31 Hoechst-Roussel Pharmaceuticals Inc. (Isoxazol-3-yl)arylmethanones, compositions and pharmaceutical use
DE3643957A1 (de) * 1986-12-22 1988-06-30 Bayer Ag Substituierte n-methylisoxazolidine

Also Published As

Publication number Publication date
PH24746A (en) 1990-10-01
GR3006699T3 (fi) 1993-06-30
JPS63165374A (ja) 1988-07-08
US5422342A (en) 1995-06-06
IL84841A (en) 1992-07-15
AU8258987A (en) 1988-06-23
FI875503A0 (fi) 1987-12-15
JP2703912B2 (ja) 1998-01-26
IL84841A0 (en) 1988-06-30
KR960010349B1 (ko) 1996-07-30
PT86380B (pt) 1990-11-20
DK662087D0 (da) 1987-12-16
AU599177B2 (en) 1990-07-12
FI88303B (fi) 1993-01-15
US5610146A (en) 1997-03-11
HUT47956A (en) 1989-04-28
EP0271865A2 (de) 1988-06-22
DK171894B1 (da) 1997-08-04
DE3782149D1 (fi) 1992-11-12
NO175058C (fi) 1994-08-24
PT86380A (de) 1988-01-01
DK662087A (da) 1988-06-18
NO175058B (no) 1994-05-16
ATE81344T1 (de) 1992-10-15
IE61034B1 (en) 1994-09-07
AR246528A1 (es) 1994-08-31
EP0271865A3 (en) 1990-02-07
NO875263D0 (no) 1987-12-16
EP0271865B1 (de) 1992-10-07
CA1338484C (en) 1996-07-23
DE3643012A1 (de) 1988-06-30
ES2052539T3 (es) 1994-07-16
HU201961B (en) 1991-01-28
KR880007497A (ko) 1988-08-27
ZA879400B (en) 1988-07-27
IE873418L (en) 1988-06-17
FI88303C (fi) 1993-04-26
NO875263L (no) 1988-06-20
NZ222921A (en) 1989-08-29

Similar Documents

Publication Publication Date Title
FI865369A0 (fi) N-innehaollande fusionerade heterocykliska foereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI871419A0 (fi) Kinolin-3-karboxylsyraderivat, deras framstaellning och anvaendning.
FI871828A (fi) Substituerade benzamidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI875135A0 (fi) 3-pyrrolidinyltio-1-azabicyklo/3.2.0/ hept-2-en-2-karboxylsyrafoereningar och foerfarande foer deras framstaellning.
FI871907A0 (fi) Slitageresistent och korrosionsskyddande, keramisk kromoxidbelaeggning.
FI870546A (fi) 1,4-bensoxazinderivat, deras framstaellning och anvaendning.
FI871081A (fi) 1,1-disubstituerade cyklopropanderivat, deras framstaellningsfoerfarande och anvaendning.
FI871719A0 (fi) Tiolaktam-n-aettiksyraderivat, deras framstaellning och anvaendning.
FI873295A (fi) Renin-haemmande di- och tripeptider, foerfarande foer deras framstaellning, dessa innehaollande aemnen och deras anvaendning.
FI875503A (fi) 2,3-disubstituerade isoxazolidiner, foerfarande foer deras framstaellning, dessa innehaollande aemnen och deras anvaendning.
FI870342A (fi) Aminderivator, foerfarande foer deras framstaellning och deras anvaendning.
FI874548A (fi) Hydroxikarboxylsyraderivat, foerfarande foer deras framstaellning och deras anvaendning i tryck- eller vaermekaensliga maerkmaterial.
FI871953A0 (fi) Papperslimaemnen, deras framstaellning och anvaendning.
FI874121A (fi) Heterocykliska foereningar, och deras framstaellning och anvaendning.
FI871813A0 (fi) Benzodiazepinderivat, deras framstaellningsfoerfarande och dessa innehaollande laekemedel och deras anvaendning.
FI875164A (fi) Hartsbelagda, icke-absorberande, kornformiga, pesticidhaltiga kompositioner och foerfarande foer deras framstaellning.
FI871448A (fi) Bis-tertiaerbutylaminosubstituerade 1,3,5-triazinderivat, foerfaranden foer deras framstaellning, dessa foereningar innehaollande laekemedel och deras anvaendning.
FI875509A (fi) Oxadiazolonderivat, foerfarande foer framstaellning daerav och herbicid innehaollande detsamma.
FI863108A0 (fi) 3,7-disubstituerade 3-kefemfoereningar och foerfarande foer deras framstaellning.
FI873192A (fi) 1,3-propandiaminderivat, foerfarande och farmaceutiska kompositioner innehaollande dessa.
FI885336A (fi) 5,6,7,8-tetrahydro-4h-isoxazolo/4,5/ azepinderivat, deras isomerer och syra-additionssalter.
FI861194A0 (fi) Substituerade 1,8-naftyridinoner, foerfarande foer deras framstaellning och farmaceutiska blandningar innehaollande dessa.
FI864766A0 (fi) Stavkonstruktion, skarvprofil och foerfarande.
FI865309A (fi) Beslagssystem, faestorgan och ytskiva foer beslag.
FI910176A0 (fi) Heteroaryletylaminer, foerfarande foer deras framstaellning och i foerfarandet anvaendbara mellanprodukter.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT